Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Reports $29.3M in Revenues

NEW YORK, Oct. 15 (GenomeWeb News) - Molecular Devices of Sunnyvale, Calif., yesterday reported revenues of $29.3 million for the third quarter ending Sept. 30, compared to $26 million for the same period in 2002.

 

The company had net income of $2.3 million for the period, compared to $1.8 million for the year-ago quarter, while spending $4.65 million on research and development, compared to $4.61 million for the same period in 2002.

 

The firm reported $102 million in total assets, including $42 million in cash and cash equivalents for the quarter, compared to $105 million in total assets and $44 million in cash and cash eqivalents for the same period a year ago.

 

In a statement, the firm said it expects revenues of $32 million to $34 million for the fourth quarter, and $114 million to $116 million for the year.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.